Mark M. Uslan
Research Subjects
Mark M. Uslan has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Darren M. Burton
American Foundation for the Blind, Huntington, West Virginia
2 shared publicationsBruce S Chertow
Joan C. Edwards School of Medicine at Marshall University, Marshall University Diabetes Center, Huntington, West Virginia
1 shared publicationBruce S. Chertow
Joan C. Edwards School of Medicine at Marshall University, Marshall University Diabetes Center, Huntington, West Virginia
1 shared publicationCaesar Eghtesadi
Managing consultant, AFB Consulting, American Foundation for the Blind, 11 Penn Plaza, Suite 300, New York, NY 10001
1 shared publicationCharles W. Clements
American Foundation for the Blind, Huntington, West Virginia
1 shared publicationDarren Burton
American Foundation for the Blind, Technology and Employment Center at Huntington, Huntington, West Virginia
1 shared publication
Latest Publications
- Open Access
- 1 September 2010
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 4 (5) , 1236-1237
Analysis: Including Visually Impaired Participants in Validation Design Studies of Diabetes Technology
In an article in this issue of Journal of Diabetes Science and Technology, Sherwyn Schwartz, M.D., presents a study to validate the design of the ClikSTAR® insulin pen from sanofi-aventis and demonstrates that the device can be used correctly by participants with diabetes. Concern with this article lies with the selection of participants, which was meant to reflect the intended audience for the insulin pen device but does not address the inclusion of visually impaired individuals, who comprise over 20% of the adult diabetes population. Visually impaired individuals need to be included as part of the intended audience for insulin administration technology, and manufacturers of these devices need to design their products for safe use by all people, including those who are visually impaired. The study demonstrated successful use of the ClikSTAR insulin pen in a population that did not include subjects with severe visual impairment. We believe that future validation studies for insulin administration technology should also include samples of visually impaired users and that visually impaired patients will embrace the use of insulin pens designed with their needs in mind.
- 1 September 2010
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 4 (5) , 1236-1237
Open AccessAnalysis: Including Visually Impaired Participants in Validation Design Studies of Diabetes Technology
In an article in this issue of Journal of Diabetes Science and Technology, Sherwyn Schwartz, M.D., presents a study to validate the design of the ClikSTAR® insulin pen from sanofi-aventis and demonstrates that the device can be used correctly by participants with diabetes. Concern with this article lies with the selection of participants, which was meant to reflect the intended audience for the insulin pen device but does not address the inclusion of visually impaired individuals, who comprise over 20% of the adult diabetes population. Visually impaired individuals need to be included as part of the intended audience for insulin administration technology, and manufacturers of these devices need to design their products for safe use by all people, including those who are visually impaired. The study demonstrated successful use of the ClikSTAR insulin pen in a population that did not include subjects with severe visual impairment. We believe that future validation studies for insulin administration technology should also include samples of visually impaired users and that visually impaired patients will embrace the use of insulin pens designed with their needs in mind.
- Open Access
- 1 April 2009
- Published by SAGE Publications in Journal of Visual Impairment & Blindness
- Vol. 103 (4) , 223-229
A Study of Multifunctional Document Centers that are Accessible to People who are Visually Impaired
- 1 April 2009
- Published by SAGE Publications in Journal of Visual Impairment & Blindness
- Vol. 103 (4) , 223-229
Open AccessA Study of Multifunctional Document Centers that are Accessible to People who are Visually Impaired
- Open Access
- 1 March 2008
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 2 (2) , 284-287
Blood Glucose Meters That Are Accessible to Blind and Visually Impaired Persons
Blood glucose meters (BGMs) that can be used nonvisually or with a visual limitation were introduced in the mid-1990s, but it was not until 2006 and 2007 that a new set of meters with accessibility features were introduced: Prodigy, Prodigy Autocode, and Prodigy Voice (Diagnostic Devices, Charlotte, NC), and Advocate and Advocate Redi-Code (TaiDoc, Taiwan). Accessibility attributes of the newly introduced BGMs were tabulated, and product design features were examined and documented. The Prodigy Voice was found to be the only one of these new BGMs that is fully usable by blind and visually impaired persons.
- 1 March 2008
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 2 (2) , 284-287
Open AccessBlood Glucose Meters That Are Accessible to Blind and Visually Impaired Persons
Blood glucose meters (BGMs) that can be used nonvisually or with a visual limitation were introduced in the mid-1990s, but it was not until 2006 and 2007 that a new set of meters with accessibility features were introduced: Prodigy, Prodigy Autocode, and Prodigy Voice (Diagnostic Devices, Charlotte, NC), and Advocate and Advocate Redi-Code (TaiDoc, Taiwan). Accessibility attributes of the newly introduced BGMs were tabulated, and product design features were examined and documented. The Prodigy Voice was found to be the only one of these new BGMs that is fully usable by blind and visually impaired persons.
- 1 March 2007
- Vol. 1 (2) , 218-27
Accessibility of home blood pressure monitors for blind and visually impaired people.
The prevalence of hypertension comorbid with diabetes is a significant health care issue. Use of the home blood pressure monitor (HBPM) for aiding in the control of hypertension is noteworthy because of benefits that accrue from following a home measurement regimen. To be usable by blind and visually impaired patients, HBPMs must have speech output to convey all screen information, an easily readable visual display, identifiable controls that are easy to use, and an accessible user manual. Data on the physical aspects and the features and functions of nine Food and Drug Administration-approved HBPMs (eight of which were recommended by the British Hypertension Society) were tabulated and analyzed for usability by blind and visually impaired individuals. Video Electronics Standards Association standards were used to measure contrast modulation in the displays of the HBPMs. Ten persons who are blind or visually impaired and who have diabetes were surveyed to determine how they monitor their blood pressure and to learn their ideas for improvements in usability. Physical controls were found to be easy to identify, and operating procedures were found to be relatively simple on all of the HBPMs, but user manuals were either inaccessible or minimally accessible to blind persons. The two HBPMs that have speech output do not voice all of the information that is displayed on the screen. Some functions that are standard in the HBPMs without speech output, such as the feature for automatically setting cuff inflation volume and memory, were lacking in the HBPMs with speech output. These features were mentioned as desirable in interviews with legally blind persons who are diabetic and who monitor their blood pressure at home. Visual display output was large and adequate in all of the HBPMs. Michelson contrast for numeric digits in the HBPM displays was also measured, ranging from 55 to 75% for characters with dominant spatial frequency components lying in the range of 0.5-1.0 cycles/degree. Home blood pressure monitors are easy-to-use devices that do not present accessibility barriers that are difficult to surmount, either technically or operationally. Two HBPMs with voice output were found to have a significant degree of accessibility, but they were not found to offer as many features as those HBPMs that were less accessible. Recommendations were made to improve accessibility, including the development of visual display standards that specify a minimally acceptable level of Michelson contrast.
- 1 March 2007
- Vol. 1 (2) , 218-27
Accessibility of home blood pressure monitors for blind and visually impaired people.
The prevalence of hypertension comorbid with diabetes is a significant health care issue. Use of the home blood pressure monitor (HBPM) for aiding in the control of hypertension is noteworthy because of benefits that accrue from following a home measurement regimen. To be usable by blind and visually impaired patients, HBPMs must have speech output to convey all screen information, an easily readable visual display, identifiable controls that are easy to use, and an accessible user manual. Data on the physical aspects and the features and functions of nine Food and Drug Administration-approved HBPMs (eight of which were recommended by the British Hypertension Society) were tabulated and analyzed for usability by blind and visually impaired individuals. Video Electronics Standards Association standards were used to measure contrast modulation in the displays of the HBPMs. Ten persons who are blind or visually impaired and who have diabetes were surveyed to determine how they monitor their blood pressure and to learn their ideas for improvements in usability. Physical controls were found to be easy to identify, and operating procedures were found to be relatively simple on all of the HBPMs, but user manuals were either inaccessible or minimally accessible to blind persons. The two HBPMs that have speech output do not voice all of the information that is displayed on the screen. Some functions that are standard in the HBPMs without speech output, such as the feature for automatically setting cuff inflation volume and memory, were lacking in the HBPMs with speech output. These features were mentioned as desirable in interviews with legally blind persons who are diabetic and who monitor their blood pressure at home. Visual display output was large and adequate in all of the HBPMs. Michelson contrast for numeric digits in the HBPM displays was also measured, ranging from 55 to 75% for characters with dominant spatial frequency components lying in the range of 0.5-1.0 cycles/degree. Home blood pressure monitors are easy-to-use devices that do not present accessibility barriers that are difficult to surmount, either technically or operationally. Two HBPMs with voice output were found to have a significant degree of accessibility, but they were not found to offer as many features as those HBPMs that were less accessible. Recommendations were made to improve accessibility, including the development of visual display standards that specify a minimally acceptable level of Michelson contrast.
- 1 August 2005
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 7 (4) , 627-628
Analysis: Beyond the "Clicks" of Dose Setting in Insulin Pens
- 1 August 2005
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 7 (4) , 627-628
Analysis: Beyond the "Clicks" of Dose Setting in Insulin Pens
- 1 October 2004
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 6 (5) , 621-634
Accessibility of Insulin Pumps for Blind and Visually Impaired People
Background: Continuous subcutaneous insulin infusion using an insulin pump (IP) more closely mimics the normal pancreas than multiple insulin injections. It is an effective, and often a preferred, means of maintaining normal blood glucose levels, but IPs were not designed to be fully accessible to blind or visually impaired people. This study will identify accessibility issues related to the design of IPs and focus on the key improvements required in the user interface to provide access for people who are blind or visually impaired. Methods: IPs that are commercially available were evaluated, and features and functions such as operating procedures, user interface design, and user manuals were tabulated and analyzed. Potential failures and design priorities were identified through a Failure Modes and Effects Analysis (FMEA). Results: Although the IPs do provide some limited audio output, in general, it was found to be of minimal use to people who are blind or visually impaired. None of the IPs uses high-contrast displays with consistently large fonts preferred by people who are visually impaired. User manuals were also found to be of minimal use. Results of the FMEA emphasize the need to focus design improvements on communicating and verifying information so that errors and failures can be detected and corrected. Conclusions: The most important recommendation for future IP development is speech output capability, which, more than any other improvement, would break down accessibility barriers and allow blind and visually impaired people to take advantage of the benefits of IP technology.
- 1 October 2004
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 6 (5) , 621-634
Accessibility of Insulin Pumps for Blind and Visually Impaired People
Background: Continuous subcutaneous insulin infusion using an insulin pump (IP) more closely mimics the normal pancreas than multiple insulin injections. It is an effective, and often a preferred, means of maintaining normal blood glucose levels, but IPs were not designed to be fully accessible to blind or visually impaired people. This study will identify accessibility issues related to the design of IPs and focus on the key improvements required in the user interface to provide access for people who are blind or visually impaired. Methods: IPs that are commercially available were evaluated, and features and functions such as operating procedures, user interface design, and user manuals were tabulated and analyzed. Potential failures and design priorities were identified through a Failure Modes and Effects Analysis (FMEA). Results: Although the IPs do provide some limited audio output, in general, it was found to be of minimal use to people who are blind or visually impaired. None of the IPs uses high-contrast displays with consistently large fonts preferred by people who are visually impaired. User manuals were also found to be of minimal use. Results of the FMEA emphasize the need to focus design improvements on communicating and verifying information so that errors and failures can be detected and corrected. Conclusions: The most important recommendation for future IP development is speech output capability, which, more than any other improvement, would break down accessibility barriers and allow blind and visually impaired people to take advantage of the benefits of IP technology.
- 1 June 2003
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 5 (3) , 439-448
Accessibility of Blood Glucose Monitoring Systems for Blind and Visually Impaired People
Blindness and visual impairment are prevalent among people with diabetes. Blood glucose monitoring systems (BGMSs) have revolutionized diabetes care, but none of the 30 or so commercially available monitoring systems was designed to be fully accessible to blind and visually impaired persons. Seventeen BGMSs were evaluated for accessible use by people who are blind or visually impaired. Features and functionalities (e.g., operating procedures, user interface design, device specifications, and computer interface capabilities) were examined and tabulated, as was usability and accessibility. A subset of these systems with the highest degree of accessibility was selected and thoroughly examined and tested. Additionally, 12 people who are blind or visually impaired and who were issued BGMSs by their physician or diabetes educator were interviewed and videotaped using their meters. Of the 17 BGMSs, only four had voice output capability, an essential component of accessibility for blind and visually impaired persons. The six BGMSs without voice output that had the largest display fonts were found to have few accessibility features for visually impaired persons. Users indicated that voice output and portability were desired attributes of an accessible BGMS. None of the BGMSs evaluated had all of the required accessibility attributes, including the four systems that had voice output capability. The four systems with voice output were much bulkier and heavier than those that did not have this capability. Recommendations are made for design and development of BGMSs that would increase effective usage by blind and visually impaired persons, including integrating text to speech and streamlining the blood glucose monitoring process.
- 1 June 2003
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 5 (3) , 439-448
Accessibility of Blood Glucose Monitoring Systems for Blind and Visually Impaired People
Blindness and visual impairment are prevalent among people with diabetes. Blood glucose monitoring systems (BGMSs) have revolutionized diabetes care, but none of the 30 or so commercially available monitoring systems was designed to be fully accessible to blind and visually impaired persons. Seventeen BGMSs were evaluated for accessible use by people who are blind or visually impaired. Features and functionalities (e.g., operating procedures, user interface design, device specifications, and computer interface capabilities) were examined and tabulated, as was usability and accessibility. A subset of these systems with the highest degree of accessibility was selected and thoroughly examined and tested. Additionally, 12 people who are blind or visually impaired and who were issued BGMSs by their physician or diabetes educator were interviewed and videotaped using their meters. Of the 17 BGMSs, only four had voice output capability, an essential component of accessibility for blind and visually impaired persons. The six BGMSs without voice output that had the largest display fonts were found to have few accessibility features for visually impaired persons. Users indicated that voice output and portability were desired attributes of an accessible BGMS. None of the BGMSs evaluated had all of the required accessibility attributes, including the four systems that had voice output capability. The four systems with voice output were much bulkier and heavier than those that did not have this capability. Recommendations are made for design and development of BGMSs that would increase effective usage by blind and visually impaired persons, including integrating text to speech and streamlining the blood glucose monitoring process.